Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Colibrí™, COPAN's Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System


News provided by

COPAN Diagnostics, Inc.

Oct 10, 2022, 15:22 ET

Share this article

Share toX

Share this article

Share toX

MURRIETA, Calif., Oct. 10, 2022 /PRNewswire/ -- COPAN Diagnostics Inc. is proud to announce the second FDA clearance of Colibrí™, a semi-automated pre-analytical processor that is a complementary part of WASPLab®, COPAN's full laboratory automation system.

Continue Reading

COPAN announces FDA clearance of Colibrí™ to automatically prepare McFarland AST suspensions & MALDI-TOF ID targets

Post this
Colibrí™, COPAN’s Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System
Colibrí™, COPAN’s Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System

Colibrí™ system is an in vitro fully automated specimen workup platform designed to prepare MALDI-TOF ID targets and create bacterial suspensions for antibiotic susceptibility testing (AST). It comprises of Colibrí™ Vision System and Colibrí™ Preparation Station. This new Colibrí™ 510(k) clearance announcement is exciting because it substantiates that fully automated culture workup for ID and AST is possible. "COPAN is committed to continue to expand the capabilities of Colibrí™ to manage other AST platforms and the Company continues to innovate to remain at the leading edge of automation for clinical microbiology," stated Norman Sharples, COPAN Diagnostics' CEO and Co-Founder.

In December 2021, COPAN announced the FDA 510(k) clearance of Colibrí™ for use with MALDI-TOF MS analyzers. This same instrument has now received its second FDA 510(k) clearance for the preparation of microbial suspensions for AST with bioMérieux VITEK 2, making Colibrí™ the first instrument in its class to receive 510(k) clearance for simultaneous preparation of MALDI-TOF slides and McFarland AST suspensions.

"Clinical microbiology is facing tremendous challenges, including labor shortages, dramatically increased workloads, pressure for on-demand testing, and rapid turnaround times for results. The FDA clearance of COPAN's Colibrí™ for MALDI and now Vitek 2 will save time and labor by automating crucial steps in diagnostic microbiology. When used with COPAN's advanced AI software, the laboratory has total traceability and precision regarding colony selection and transfer to MALDI-TOF target slides and now AST tube preparation. Complex tasks that occur tens of thousands of times per day in microbiology laboratories require great care and attention. Such tasks are now fully automated with unquestionable accuracy. With these critical processes in laboratory workup automated and interfaced with downstream mass spectrometry instruments and Vitek 2, experienced laboratory professionals may now use their time to perform other complex tasks requiring their unique skills and expertise," added Sharples.

The Colibrí™ system, paired with Copan's revolutionary artificial intelligence (AI) software, PhenoMATRIX®Elite with TAG, offers clinical Microbiology laboratories cutting-edge, intelligence-driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory. "COPAN continues to develop robotic and AI-driven solutions for clinical laboratories as our commitment to innovating together is the heart of our Company," concluded Sharples.

About Colibrí™

COPAN's Colibrí™ automatically picks isolated colonies for further workup and investigations. Colonies are designated by the laboratory technologist or automatically by COPAN's advanced AI, PhenoMATRIX® TAG. The precision robotics of full laboratory automation system WASPLab® combined with Colibrí™ help to eliminate any transposition errors.

Colibrí™ works with both bioMérieux VITEK® MS and Bruker Biotyper systems, seeding either manufacturers' target plate formats, automatically applying matrix, and automatically sends instructions and coordinates identifying each culture workup spot.

Colibrí™ seeds colonies into various-size tubes to prepare McFarland suspensions for AST. The system is now FDA cleared for the preparation of microbial suspensions for AST with bioMérieux VITEK 2.

About PhenoMATRIX™

PhenoMATRIX® is an unparalleled AI-powered software suite that uses an advanced selection of highly sophisticated algorithms which gives users of COPAN's full laboratory automation WASPLab® the power to automatically pre-assess, pre-sort and segregate bacterial cultures. PhenoMATRIX® allows laboratories to quickly view and discard up to 80% of negative cultures with the click of a button. 

PhenoMATRIX® TAG is the latest evolution of COPAN's advanced AI to detects and "tags" the best colonies to be picked by Colibrí™ for workup. The PhenoMATRIX® TAG software highlights isolated and aggregated colonies. After defining the optimal colonies for selection, PhenoMATRIX® TAG communicates the colony coordinates to the Colibrí™ for reliable and accurate picking.

About COPAN Full Laboratory Automation WASPLab®

WASPLab® is a highly efficient, modular, scalable, and customizable specimen processing and culture workup system for clinical microbiology. Samples move from front-end processing to smart incubation, digital microbiology, and artificial intelligence for plate reading. 

About COPAN Diagnostics, Inc.

COPAN Diagnostics is part of COPAN Group, a leading manufacturer of collection and transport systems and full laboratory automation in the world. With a reputation for innovation, COPAN's collaborative approach to pre-analytics has resulted in FLOQSwabs®, ESwab™, UTM Universal Transport Medium®, laboratory automation including WASP® and WASPLab® and Microbiology laboratory artificial intelligence software PhenoMATRIX®. For more information, visit www.copanusa.com

SOURCE COPAN Diagnostics, Inc.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Copan Expands U.S. Manufacturing Footprint with Multimillion-Dollar Investment

Copan Expands U.S. Manufacturing Footprint with Multimillion-Dollar Investment

Copan Diagnostics, part of the privately held Italy-based Copan Group and a leader in specimen collection and transport, and laboratory automation,...

Copan Launches UriVerse™: Fully Automated Solution for Urine Specimen Aliquoting

Copan Launches UriVerse™: Fully Automated Solution for Urine Specimen Aliquoting

Copan, a leader in microbiology laboratory and automation innovations, proudly announced the official launch of UriVerse™ during the Association for...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Clinical Trials & Medical Discoveries

Clinical Trials & Medical Discoveries

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.